Dr Reddy's launches a new generic drug in the US

Dr Reddy’s announces the launch of Memantine hydrochloride tablets in the American market

id-100265010

Memantine hydrochloride tablets are a therapeutic equivalent generic version of NAMENDA

Dr Reddy's Laboratories has announced that it has launched Memantine hydrochloride tablets USP, 5 mg and 10 mg, a therapeutic equivalent generic version of NAMENDA (memantine HCl)tablets in the US market.

The NAMENDA (memantine HCl) tablets brand had the US sales of approximately $1.4 billion MAT for the most recent twelve months ending in May 2015, according to IMS Health.

The company's Memantine hydrochloride tablets USP, 5 mg is available in bottle count size of 60 and the Memantine hydrochloride tablets USP, 10 mg are available in bottle count sizes of 60 and 500.

 

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

GST

GST: Boon or Bane for Healthcare?

Send this article by email

X